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Aims: To report the conclusions of the Think Tank on mechanisms of incontinence and surgical cure in female and
male SUI: surgical research initiatives during the ICI-RS meeting in 2010. Methods: The sub-group considered five
areas for future research in stress urinary incontinence (SUI); (i) epidemiology and public health efforts in SUI, (ii) the
basic sciences examining the physiology and pathophysiology of the continence mechanism, (iii) diagnostic techniques
and clinical assessment of SUI, (iv) the future of treatment and surgical cure, and (v) the separate issue of male SUI.
Results: Roadblocks to progress were identified for each of the five directions. Conclusions: Future research direc-
tions are suggested for each of these areas. Neurourol. Urodynam 30:704–707, 2011.  2011 Wiley-Liss, Inc.
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INTRODUCTION
Stress urinary incontinence (SUI) is defined as the loss of
urine with effort (an increase in intra-abdominal pressure
which overcomes the urethral resistance in the absence of a
true bladder contraction). The entire group who elected this
Think Tank identified areas of future research, purposely
inclusive of a broad range of research interests; epidemiology
and public health, pathophysiology, diagnosis, treatment, and
the male patient. The inclusion of the male patient was based
on the perception by the group of a relatively disproportionate
historical focus on the female patient in the SUI literature,
particularly in the basic sciences. Each sub-group identified an
area or areas of interest within their topic based on a balance
between the perceived need for further research and the avail-
able knowledge base.
EPIDEMIOLOGY AND PUBLIC HEALTH EFFORTS IN SUI
Advances in epidemiology are required to prioritize research
into the utilization and development of both current and
evolving treatment options. Surgical research must be able to
identify and understand the population at risk. The threshold
for treatment of SUI differs depending on cultural norms, the
source of payment for various treatments, and expectations of
outcome. Representatives from disparate geographic medical
systems agree that all countries are struggling with algor-
ithms to best utilize available resources. Simple questions per-
sist about which patient benefits from which treatment.
There is an acknowledged disconnect between objective
severity of SUI (frequency of incontinence, volume of urine
loss) and the subjective bother to the individual. Co-morbid-
ities such as obesity and diabetes are increasing and may have
deleterious effects on the management of SUI. A ‘‘needs
assessment’’ instrument is essential for creating an accurate
resource allocation for the types of therapy that will be
required by evolving sub-populations (e.g., aging population
and those patients with concomitant co-morbidities).
Little progress has been made in the prevention of SUI.
Because SUI is common in women, has a significant effect on
quality of life, and is not always treated successfully, therefore
prevention of SUI (primary, secondary, and tertiary) should be
a higher priority. The contribution of family history has been
found to play an important role in SUI, and genetics may have
contributions to the development of SUI equal to that of
environment; approximately 40% has been ascribed to each
according to twin studies. We may be able to use enriched
study populations (i.e., higher risk groups such as those with a
family history) to facilitate prevention studies.
THE BASIC SCIENCES EXAMINING THE PHYSIOLOGY AND
PATHOPHYSIOLOGY OF THE CONTINENCE MECHANISM
A better understanding of the pathophysiology of SUI is
needed specifically by expanding basic science research of the
continence mechanism. While many factors can contribute to
SUI, we shall argue that recent research suggests that one of
the most important is maximum urethral closure pressure
(MUCP). There is generally a wide variation in MUCP in
healthy continent nullipara. For example, in the third decade
MUCP averages 92 cm H2O and ranges from about 70 to
115 cm H20, but by the seventh decade the effect of age has
caused it to decrease to an average of 37 cm H2O and few val-
ues exceed 50 cm H2O.
1 While part of this age-related loss in
MUCP can probably be attributed to an age-related loss in
smooth muscle cell density observed,2 some may be caused by
the age-related loss of striated urethral muscles cells3,4 as well
as the urethral nerve axons.5 While these in vitro studies are
valuable, there remains the need to directly correlate urethral
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striated and smooth muscle volume and quality with MUCP
in vitro. Present ultrasound and MR techniques will need to be
further improved before this can be done reliably. In parous
women there is weak histological evidence that some of the
loss in urethral striated muscle and nerve is related to par-
ity.3–5 And it is known that parity adversely affects MUCP: for
example, the MUCP in primipara with de novo SUI average
63 cm H2O compared with 90 cm H2O in nulliparous conti-
nent controls.6 This is important because decreased MUCP is
now known to be a slightly stronger contributor to SUI than
urethral hypermobility.7 From a functional standpoint one
knows that the lower the MUCP the higher the risk of SUI,
which occurs whenever intra-abdominal pressure exceeds
MUCP.8 Hence, one might expect that a nullipara starting
adult life with a low MUCP is more likely to leak when she is
older than a nullipara with a high initial MUCP; but this
remains to be proven. Racial differences in MUCP have been
found: whites average 22% lower MUCP than blacks (56 cm
H2O vs. 68 cm H2O).
9 Why this racial difference is present is
not yet clear. Does the difference lie, for example, in the stri-
ated or smooth muscle tone or volume, or the blood pressure
in the vascular plexus? What is known is that, when either
group has SUI, their MUCP is about 20% lower than normal.8
Despite the wealth of data on MUCP it is an inconvenient
truth, and an opportunity for future research, that all past and
current measurements of MUCP suffer from systematic
measurement bias. Firstly, any published measurement of
urethral closure pressure contains measurement artifact, due
to the diameter of the current urodynamics catheters disturb-
ing the physiology of what is being measured: for example, a
6 or 8 F catheter will part and unfold the coapted surfaces of
the urethral lumen merely to gain access to the lumen, and
inspection of axial MR and histological cross-sectional urethral
anatomy10 would suggest that the catheter likely partially
occludes the vascular plexus, and possibly lengthens the cir-
cumferentially arranged sphincteric muscle layers. The latest
generation of ultraminiature pressure transducers, measuring
fractions of a millimeter, would avoid some, but not all of
these problems. Second, the radial and flexural stiffness of the
current catheters is considerably stiffer than that of the ure-
thral lumen, vascular plexus, and sphincter muscles. This
means that it probably tends to straighten a curved urethra
on the one hand, and also tend to prevent a urethra from
bending naturally along its length during a cough or valsalva,
on the other. Both effects can foster measurement artifact.
Thirdly, the longitudinal stiffness of the catheter means that
it may be difficult to eliminate movement of the urethral
mucosa relative to the longitudinal axis of the catheter during
a cough or sneeze.11 This particular artifact can be eliminated
through use of a suction port.11 Fourthly, current urodynamics
catheters fail to allow one to differentiate between fluid pres-
sure and a contact stress applied to the sensor. The former is
the urine pressure at that location, while the latter is due to
the direct contact of the mucosal tissues on the pressure sen-
sor. The two are not necessarily equivalent. Novel methods
are being explored to examine urethral function,12 however,
these need to be further miniaturized so as to avoid altering
the very physiology that they are studying, for the reasons
already given.
Modern methods of tissue engineering allow one to grow
scaffold-less ligament and muscle tubular structures that per-
mit nerve and blood vessel growth along those tubes.13 How-
ever, much work remains to be done to grow anything that
resembles the sophistication of a urethra complete with
lumen, vascular plexus, and smooth and striated muscle
layers with ability to be controlled neurologically. This brings
up the question as to how much each of those layers contrib-
utes to MUCP. The current dogma, reviewed by Ashton-Miller
and DeLancey,14 is that the vascular layer, smooth muscle,
and striated muscle layers each contribute 33% to MUCP.
However, the data are based on a small study using older
methods. Given the importance of low MUCP to SUI, a current
knowledge gap is how much each of these layers contribute to
MUCP in health, age, and disease. What exactly underlies, for
example, the loss in MUCP, discussed above, that has been
documented with age and parity? The answer would help
direct future tissue engineering efforts by identifying tissue
impairment causing the greatest deficit in MUCP.
Lastly, much is known about the neural control of the
rodent urethra,15 but less is known about the control of the
human urethra and pelvic floor in vivo. In vivo studies are
starting to be performed16 but more are needed. What func-
tion, for example, does the longitudinal smooth muscle of the
urethra have? Is it involved in the initiation of micturition by
exerting tension to help open the vesical neck? Finite element
models might give useful insights in this regard.
DIAGNOSTIC TECHNIQUES AND CLINICAL ASSESSMENT FOR SUI
An accurate diagnosis is essential for the implementation of
effective and efficient treatment algorithms in SUI, as well as
the subjective and objective assessment of treatment out-
comes. However, the sub-group recognizes the need to priori-
tize these research goals due to the limited resources in less
developed countries as well as the potential for limits on
future health research expenditures in any country. Complex
testing such as urodynamics is widely recommended for the
assessment of SUI, even though the equipment required is
expensive and not readily available. The concept that ‘‘the
bladder is an unreliable witness’’ stemmed from the lack of
correlation between patient symptoms and the results of such
high tech testing. The testing was said to be of more con-
sequence than the patient’s own complaints, but there is little
evidence that such testing is needed prior to surgery for SUI
(see sub-committee statement on ‘‘urodynamics’’). The sub-
committee recommended that no further clinical tests should
be utilized in the routine evaluation of SUI without evidence
of its usefulness, especially those involving significant
expense or discomfort to the patient. Current clinical testing
should continue to be subjected to these standards of evi-
dence-based utility, and a high priority is to develop clinical
testing that predicts which patients benefit from which
treatments.
THE FUTURE OF TREATMENT AND SURGICAL CURE
Priorities in surgical treatment were detailed in the 1st ICI-
RS and include (i) the creation of large-scale collaborative
databases designed to foster high-quality data collection, (ii)
the development of a system of standardized outcome
measures, (iii) the selection of treatments/procedures to be
placed in the database, and (iv) the establishment of an
organizational structure to be responsible for instituting the
standards and procedural mechanisms to ensure the integrity
of the data analysis.17 It was agreed by the committee that
the first surgery is likely to yield the best results, and that all
secondary treatments are likely to be less effective. Thus,
the concept of surgical cure must take into account whether
the treatment is primary or secondary. Reimbursement for
treatment of SUI in most countries is NOT based on treatment
outcomes. Much could be learned by concentrating on
surgical failures. This sub-group concentrated on the need for
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research that will improve the metrics for evaluating
patient expectations prior to, and satisfaction after, surgical
intervention.
There is a lack of data regarding patient expectations for
treatment of SUI. In addition, there is considerable evidence
that there may be a discrepancy between patient satisfaction
and objective outcome measures. Compared to currently
favored quality of life measures, an individual-patient goal-
driven approach which uses composite endpoints may more
clinically meaningful.18–22
While disease specific QoL questionnaires allow broad com-
parisons to be made assessing patient bother they may lack
the sensitivity to assess individual symptoms. Isolated ‘‘objec-
tive’’ measures such as standard volume stress test and urody-
namics are less likely to document stress leakage in women,
and when used as the primary endpoint in a surgical trial,
may yield more favorable ‘‘success rates’’ compared to subjec-
tive outcomes.23 Composite outcomes encompassing multiple
objective and subjective measures to define treatment success
are likely to have lower ‘‘success rates’’ in the same individual.
Comparison between studies would be facilitated by the use
of a single composite measure. Increased use of databases to
compare outcomes and adverse events (AE) is advocated.
The group identified as a high priority the ability to improve
communication between the physician and patient, including
an improved understanding of physician-based outcomes
(e.g., safety, morbidity, efficacy, efficiency) and patient-cen-
tered outcomes (e.g., patient preferences, expectations, and
satisfaction). In addition, the committee identified the need
for research into alternative therapies for the treatment of
SUI, including new surgical techniques and new implant
materials for stress incontinence surgery which are developed
in parallel with defined pathways for introducing these thera-
pies into general clinical practice. Communicating and trans-
lating the surgeon’s expectations of treatment outcomes into
the patient’s set of expectations will improve the informed
consent process.
There is general agreement that many efficacy outcomes
remain poorly defined.17 However, equally as critical, the defi-
nition and classification of AE and the ‘‘morbidity-impact’’ of
these specific AEs also requires further research. Research is
needed to understand the impact of specific AEs on the indi-
vidual patient as opposed to the incidence of the AE in a popu-
lation—and the relative impact of the specific AE to the pre-
surgical condition of the individual patient. The terminology
to classify AEs is deficient as descriptors such as ‘‘pre-op’’ also
do not reflect the impact or bother of the AE, especially with
respect to the trade-off between the ‘‘de novo’’ or worsened
post-operative symptoms and the desired and perceived
improvement from the surgery. Due to the need to understand
the incidence and impact of AEs, and given the possibility of
limited resources, the committee suggested that a compli-
cations registry with a known denominator would be of the
most immediate benefit to patient care, although a compre-
hensive data registry that also details efficacy is unquestion-
ably preferable.
Specific to urinary incontinence is the interrelationship
between stress and urgency incontinence (or OAB dry symp-
toms). In general, a patient who has residual SUI but is
relieved of urgency symptoms will be more satisfied with
treatment than a patient who is completely cured of SUI and
has residual urgency symptoms, and certainly more than the
patient who is cured of SUI and develops urgency inconti-
nence even though the surgery was for SUI (consensus agree-
ment by the sub-committee). Clinically, this means that
women with mixed stress and urgency incontinence are more
difficult to treat because both components of their leakage
must improve for the patient to achieve continence.
THE SEPARATE ISSUE OF MALE SUI
Male urinary incontinence has been a rather neglected
research topic in comparison to the condition in females. This
is in part because of its iatrogenic nature possibly because of
the natural tendency of surgeons treating prostate cancer to
minimize the morbidity of male USI in lieu of the primary
condition they are treating. This surgical sub-group considered
areas for future research in the classification, diagnosis, and
treatment of stress incontinence in the male patient.
Male patients may suffer different forms of urinary inconti-
nence including urgency incontinence, primary stress inconti-
nence (rare), iatrogenic stress incontinence following prostate
surgery, UI associated with chronic retention (once called
overflow incontinence), and urinary incontinence associated
with post-micturition dribbling. The prevalence of SUI in the
male population is known to be lower than in female
cohorts24 primarily because the high outlet resistance of the
male urinary tract makes leakage a rare event. Epidemiology
studies suggest that men are severely bothered by SUI24 and
they find it difficult to cope with the condition. This is also
because SUI is generally considered by clinicians to be a
female issue, and pads are not in the men’s armamentarium
for other conditions. Interestingly, incontinent men seem to
suffer a larger emotional impact than women.25
Primary stress incontinence in men is rare and is usually
observed in neurogenic patients with impaired sphincter
function or in frail elderly patients.26 The prevalence of the
condition is rare enough to make clinical research a low
priority.
Iatrogenic urinary incontinence, of a degree that necessi-
tates invasive therapy, is a less common but serious compli-
cation of simple prostatectomy and transurethral resection of
the prostate.27 The condition is considered to be due to sphinc-
ter damage. Endoscopic imaging of incontinent patients
usually reveals scar tissue in the dorsal part of the external
sphincter and although active recruitment often results in
proper closure mechanism, the sphincter remains open at rest.
No major clinical questions remain open on this subject
beyond the need to provide continence rate for any new surgi-
cal procedures that becomes available for the management of
BPO.
Urinary incontinence following radical prostatectomy is the
most prevalent form of iatrogenic incontinence in urology.28
Incidence rate depend upon the definition of continence (e.g.,
dry or no pads vs. a single protection pad), and in case series
varies between 10% and 50% at 1 year from surgery.29 No con-
sensus exists on the mechanisms underlying SUI following
radical prostatectomy and whether there are any preoperative
risk factors.29 Both sphincter and detrusor dysfunction can
play a role. SUI is clearly dependent upon sphincter incompe-
tence but it is still unclear what is the relative contribution of
neural damage, direct damage of muscle fibers, and sphincter
dislocation. A number of studies investigated preoperative
sphincter parameters such as MUCP and sphincter length try-
ing to identify threshold values associated with a higher risk
of SUI but the case remains open. Careful dissection of the
prostate apex and preservation of the neural bundles seem to
be associated with increased continence rates suggesting that
sphincter denervation may be of importance although the
data remain conflicting.30,31 Surgery of post radical prostatec-
tomy incontinence with the Advance sling results suggests
that downward dislocation of the sphincter complex may be
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responsible for suboptimal closure mechanism although
definitive proof of the concept is still lacking.32
Since 2002, when the change in terminology was adopted,
use of the old term ‘‘overflow incontinence has been discon-
tinued.’’ Although the terminology might have been inaccur-
ate, the condition remains real and patients sometimes
present with chronic retention and SUI due to volume over-
load of the urinary bladder. Research is certainly needed in
this area to identify a correct terminology to define this
condition.
CONCLUSIONS
A number of academic questions remain open and certainly
deserve properly designed, carefully conducted studies with
adequate funding. The research priorities for SUI are listed
below,
(i) Identifying the epidemiology and promoting public
health efforts: specifically, improving knowledge of the
characteristics of the ‘‘at risk’’ population, understanding
resources, and investigating methods of prevention.
(ii) Advancing the basic science understanding of the conti-
nence mechanism.
(iii) Improving diagnostic and clinical techniques.
(iv) Interpreting outcomes of surgical treatment: specifically,
re-examination of the metrics for determining patient
bother and the metrics for surgical outcomes—including
patient-driven expectations and goals.
(v) Expanding recognition and treatment of the male patient:
specifically, acknowledging the burden of disease of SUI
in the male population and applying the research initiat-
ives above (i–iv) to the male as well as the female
population.
REFERENCES
1. Trowbridge RE, Wei JT, Fenner DE, et al. Effects of aging on lower urinary
tract and pelvic floor function in nulliparous women. Obstet Gynecol
2007;109:715–720.
2. Clobes A, DeLancey JO, Morgan DM. Urethral circular smooth muscle in you-
ng and old women. Am J Obstet Gynecol 2008;198:e1–e5.
3. Perucchini D, DeLancey JOL, Ashton-Miller JA, et al. Age effects on urethral
striated muscle: I Changes in number and diameter of striated muscle fibers
in the ventral urethra. Am J Obstet Gynecol 2002;186:351–355.
4. Perucchini D, DeLancey JOL, Ashton-Miller JA, et al. Age effects urethral stri-
ated muscle: II. Anatomic location of muscle loss. Am J Obstet Gynecol
2002;186:356–360.
5. Pandit M, DeLancey JO, Ashton-Miller JA, et al. Quantification of intramus-
cular nerves within the female striated urogenital sphincter muscle. Obstet
Gynecol 2000;95:797–800.
6. DeLancey JO, Miller JM, Kearney R, et al. Vaginal birth and de novo stress
incontinence: Relative contributions of urethral dysfunction and mobility.
Obstet Gynecol 2007;110:354–362.
7. DeLancey JOL, Trowbridge ER, Miller JM, et al. Stress urinary incontinence:
Relative importance of urethral support and urethral closure pressure. J Urol
2008;179:2286–2290.
8. Kim K-J, Ashton-Miller JA, Strohbehn K, et al. The vesico-urethral pressure-
gram analysis of urethral function under stress. J Biomech 1997;30:19–25.
9. DeLancey JOL, Fenner DE, Guire K, et al. Differences in continence system
between community-dwelling black and white women with and without
urinary incontinence in the EPI study. Am J Obstet Gynecol 2010;202:
e1–e12.
10. Strohbehn K, Quint LE, Prince MR, et al. Magnetic resonance imaging
anatomy of the female urethra: A direct histologic comparison. Obstet
Gynecol 1996;88:750–756.
11. Stafford RE, Sapsford R, Ashton-Miller JA, et al. A novel transurethral surface
electrode to record male striated urethral sphincter electromyographic
activity. J Urol 2010;183:378–385.
12. Klarskov N, Lose G. Urethral pressure Re£ectometry; A novel technique for
simultaneous recording of pressure and cross-sectional area in the female
urethra. Neurourol Urodyn 2007;26:254–261.
13. Ma J, Goble K, Smietana M, et al. Morphological and functional character-
istics of three-dimensional engineered bone-ligament-bone constructs fol-
lowing implantation. J Biomech Eng 2009;131: art. no. 101017-1.
14. Ashton-Miller JA, DeLancey JOL. Functional anatomy of the female pelvic
floor. Ann NY Acad Sci 2007;1101:266–296.
15. Thor KB, deGroat WC. Neural control of the female urethral and anal rhab-
dosphincters and pelvic floor muscles. Am J Physiol Regul Integr Comp Phys-
iol 2010;299:R416–R438.
16. Junginger B, Baessler K, Sapsford R, et al. Effect of abdominal and pelvic floor
tasks on muscle activity, bladder pressure and bladder neck. Int Urogyn J
2010;21:69–77.
17. Staskin D, Khullar V. Female pelvic surgical devices and techniques need
better evidence-based medicine. Neurourol Urodyn 2010;29:670–675.
18. Tincello DG, Alfirevic Z. Important clinical outcomes in urogynaecology:
Views of patients, nurses and medical staff. Int Urogynaecol J 2002;13:96.
19. Elkadry EA, Kenton KS, Fitzgerald MP, et al. Patient selected goals: A new
perspective on surgical outcome. Am J Obstet Gynaecol 2003;189:1551–
1557.
20. Mahajan ST, Elkadry EA, Kenton KS, et al. Patient centered surgical out-
comes: The impact of goal achievement and urge incontinence on patient
satisfaction one year after surgery. Am J Obstet Gynaecol 2006;194:722–
728.
21. Lowenstein L, Fitzgerald MP, Kenton K, et al. Patient-selected goals: The
fourth dimension in assessment of pelvic floor disorders. Int Urogyn J Pelvic
Floor Dysfunct 2008;19:81–84.
22. Srikrishna S, Robinson D, Cardozo L. Qualifying a quantitative approach to
women’s expectations of continence surgery. Int Urogyn J Pelvic Floor Dys-
funct 2009;20:859–865.
23. Ward JF, Sebo TJ, Blute ML, et al. Salvage surgery for radiorecurrent prostate
cancer: Contemporary outcomes. J Urol 2005;173:1156–1160.
24. Kwong PW, Cumming RG, Chan L, et al. Urinary incontinence and quality of
life among older community-dwelling Australian men: The CHAMP study.
Age Ageing 2010;39:349–354.
25. Teunissen D, Van Den Bosch W, Van Weel C, et al. ‘‘It can always happen’’:
The impact of urinary incontinence on elderly men and women. Scand J
Prim Health Care 2006;24:166–173.
26. Miu DK, Lau S, Szeto SS. Etiology and predictors of urinary incontinence and
its effect on quality of life. Geriatr Gerontol Int 2010;10:177–182.
27. Rassweiler J, Teber D, Kuntz R, et al. Complications of transurethral resection
of the prostate (TURP)–incidence, management, and prevention. Eur Urol
2006;50:969–979.
28. Jacobsen NE, Moore KN, Estey E, et al. Open versus laparoscopic radical pros-
tatectomy: A prospective comparison of postoperative urinary incontinence
rates. J Urol 2007;177:615–619.
29. Sacco E, Prayer-Galetti T, Pinto F, et al. Urinary incontinence after radical
prostatectomy: Incidence by definition, risk factors and temporal trend in a
large series with a long-term follow-up. BJU Int 2006;97:1234–1241.
30. Potdevin L, Ercolani M, Jeong J, et al. Functional and oncologic outcomes
comparing interfascial and intrafascial nerve sparing in robot-assisted lapa-
roscopic radical prostatectomies. J Endourol 2009;23:1479–1484.
31. Toren P, Alibhai SM, Matthew A, et al. The effect of nerve-sparing surgery
on patient-reported continence post-radical prostatectomy. Can Urol Assoc J
2009;3:465–470.
32. Bauer RM, Mayer ME, Gratzke C, et al. Prospective evaluation of the func-
tional sling suspension for male postprostatectomy stress urinary inconti-
nence: Results after 1 Year. Eur Urol 2009;56:928–933.
Mechanisms of Continence and Surgical Cure, ICI-RS 2010 707
Neurourology and Urodynamics DOI 10.1002/nau
